amoxapine has been researched along with Drug-Induced Stevens Johnson Syndrome in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camisa, C | 1 |
| Grines, C | 1 |
1 other study available for amoxapine and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Amoxapine: a cause of toxic epidermal necrolysis?
Topics: Amoxapine; Dibenzoxazepines; Female; Humans; Middle Aged; Stevens-Johnson Syndrome | 1983 |